亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

The Relationship between Rate and Volume of Intravenous Fluid Administration and Kidney Outcomes after Angiography

医学 四分位间距 四分位数 优势比 置信区间 肌酐 内科学
作者
Qandeel H. Soomro,Sonia T. Anand,Steven D. Weisbord,Martin Gallagher,Ryan Ferguson,Paul M. Palevsky,Deepak L. Bhatt,Chirag R. Parikh,James S. Kaufman
出处
期刊:Clinical Journal of The American Society of Nephrology [American Society of Nephrology]
卷期号:17 (10): 1446-1456 被引量:6
标识
DOI:10.2215/cjn.02160222
摘要

Contrast-associated AKI may result in higher morbidity and mortality. Intravenous fluid administration remains the mainstay for prevention. There is a lack of consensus on the optimal administration strategy. We studied the association of periprocedure fluid administration with contrast-associated AKI, defined as an increase in serum creatinine of at least 25% or 0.5 mg/dl from baseline at 3-5 days after angiography, and 90-day need for dialysis, death, or a 50% increase in serum creatinine.We conducted a secondary analysis of 4671 PRESERVE participants who underwent angiographic procedures. Although fluid type was randomized, strategy of administration was at the discretion of the clinician. We divided the study cohort into quartiles by total fluid volume. We performed multivariable logistic regression, adjusting for clinically important covariates. We tested for the interaction between fluid volume and duration of fluid administration, categorized as <6 or ≥6 hours.The mean (SD) age was 70 (8) years, 94% of participants were male, and median (interquartile range) eGFR was 60 (41-60) ml/min per 1.73 m2. The range of fluid administered was 89-882 ml in quartile 1 and 1258-2790 ml in quartile 4. Compared with the highest quartile (quartile 4) of fluid volume, we found a significantly higher risk of the primary outcome in quartile 1 (adjusted odds ratio, 1.58; 95% confidence interval, 1.06 to 2.38) but not in quartiles 2 and 3 compared with quartile 4. There was no difference in the incidence of contrast-associated AKI across the quartiles. The interaction between volume and duration was not significant for any of the outcomes.We found that administration of a total volume of 1000 ml, starting at least 1 hour before contrast injection and continuing postcontrast for a total of 6 hours, is associated with a similar risk of adverse outcomes as larger volumes of intravenous fluids administered for periods >6 hours. Mean fluid volumes <964 ml may be associated with a higher risk for the primary outcome, although residual confounding cannot be excluded.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
8秒前
AaronW完成签到 ,获得积分10
12秒前
dbyy发布了新的文献求助10
14秒前
大熊完成签到 ,获得积分10
17秒前
19秒前
FashionBoy应助曦耀采纳,获得10
21秒前
超帅的龙猫完成签到,获得积分10
34秒前
qq完成签到,获得积分10
49秒前
李健应助曦耀采纳,获得10
1分钟前
qq发布了新的文献求助10
1分钟前
务实的犀牛完成签到,获得积分10
1分钟前
null应助科研通管家采纳,获得10
1分钟前
null应助科研通管家采纳,获得10
1分钟前
null应助科研通管家采纳,获得10
1分钟前
null应助科研通管家采纳,获得10
1分钟前
null应助科研通管家采纳,获得10
1分钟前
1分钟前
null应助科研通管家采纳,获得10
1分钟前
null应助科研通管家采纳,获得10
1分钟前
磨刀霍霍阿里嘎多完成签到 ,获得积分10
1分钟前
要减肥的春天完成签到,获得积分10
1分钟前
共享精神应助冷酷的鹏涛采纳,获得10
1分钟前
uss完成签到,获得积分10
1分钟前
阿布应助仁爱的念文采纳,获得10
2分钟前
从来都不会放弃zr完成签到,获得积分10
2分钟前
直率的雪巧完成签到,获得积分10
2分钟前
科研通AI6应助inRe采纳,获得10
2分钟前
研友_VZG7GZ应助xuzb采纳,获得10
2分钟前
2分钟前
3分钟前
斯文败类应助SiboN采纳,获得10
3分钟前
CodeCraft应助科研通管家采纳,获得10
3分钟前
思源应助科研通管家采纳,获得10
3分钟前
3分钟前
3分钟前
3分钟前
冷酷的鹏涛完成签到,获得积分10
3分钟前
3分钟前
墨薄凉完成签到 ,获得积分10
3分钟前
轻松一曲应助inRe采纳,获得10
3分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Encyclopedia of Reproduction Third Edition 3000
《药学类医疗服务价格项目立项指南(征求意见稿)》 1000
花の香りの秘密―遺伝子情報から機能性まで 800
1st Edition Sports Rehabilitation and Training Multidisciplinary Perspectives By Richard Moss, Adam Gledhill 600
Chemistry and Biochemistry: Research Progress Vol. 7 430
Bone Marrow Immunohistochemistry 400
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5628172
求助须知:如何正确求助?哪些是违规求助? 4715898
关于积分的说明 14963806
捐赠科研通 4785879
什么是DOI,文献DOI怎么找? 2555413
邀请新用户注册赠送积分活动 1516720
关于科研通互助平台的介绍 1477252